Zeltiq Aesthetics Inc (ZLTQ)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Zeltiq Aesthetics Inc (ZLTQ) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011355
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Zeltiq Aesthetics Inc (Zeltiq), a subsidiary of Allergan Plc is a medical technology company that develops and commercializes products of cooling technology. The company offers CoolSculpting System utilizing proprietary controlled-cooling technology to selectively reduce stubborn fat bulges. Its CoolSculpting System provides fat-freezing procedure and non-surgical fat-reduction treatment that uses controlled cooling to eliminate stubborn fat that resists all efforts through diet and exercise. Zeltiq offers therapies for abdomen, thigh, flank and side, and chin. The company caters to dermatologists, plastic surgeons and aesthetic specialists. It sells its products through a network of distributors in North America, Asia-Pacific, Europe, the Middle East, Africa and South America. Zeltiq is headquartered in Pleasanton, California, the US.

Zeltiq Aesthetics Inc (ZLTQ) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Zeltiq Aesthetics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Zeltiq Aesthetics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Zeltiq Aesthetics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Zeltiq Aesthetics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Zeltiq Aesthetics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Zeltiq Aesthetics Inc, Medical Equipment, Deal Details 10
Partnerships 10
Galderma Enters into Agreement with ZELTIQ Aesthetics 10
Advance Medical Enters Into Co-Marketing Agreement With Zeltiq Aesthetics For CoolSculpting System 11
Equity Offering 12
Zeltiq Aesthetics Files Registration Statement For Public Offering Of Securities For US$75 Million 12
ZELTIQ Aesthetics Completes IPO For US$101 Million 13
Acquisition 15
Allergan Acquires ZELTIQ Aesthetics for USD2.48 Billion 15
Zeltiq Aesthetics Inc – Key Competitors 17
Zeltiq Aesthetics Inc – Key Employees 18
Zeltiq Aesthetics Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
Mar 01, 2017: ZELTIQ Announces Fourth Quarter and Full Year 2016 Financial Results 20
Jan 09, 2017: ZELTIQ Reports Preliminary Fourth Quarter and Full Year 2016 Revenue and Provides 2017 Guidance 22
Nov 09, 2016: ZELTIQ Announces Third Quarter 2016 Financial Results 23
Aug 08, 2016: ZELTIQ Announces Second Quarter 2016 Financial Results 24
May 10, 2016: ZELTIQ Announces First Quarter 2016 Financial Results 26
Feb 29, 2016: ZELTIQ Announces Fourth Quarter and Full Year 2015 Financial Results 28
Jan 12, 2016: ZELTIQ Reports Preliminary Fourth Quarter and Full Year 2015 Revenue 30
Corporate Communications 32
Jan 09, 2017: ZELTIQ Aesthetics Announces Commercial Leadership Transition 32
Apr 26, 2016: Hospira President, David J. Endicott, Joins ZELTIQ Aesthetics Board of Directors 33
Jan 12, 2016: ZELTIQ Announces Executive Leadership Addition and Global Commercial Operations Realignment 34
Product News 35
03/03/2016: ZELTIQ Launches 3-in-1 CoolAdvantage Applicator for the CoolSculpting System at American Academy of Dermatology Annual Meeting 35
03/02/2016: Newport Beach Dermatologist Reveals Benefits of CoolMini for Double Chin Reduction 37
02/09/2016: Introducing the CoolMini Applicator for Coolsculpting Treatment at Laser Therapy Health & Wellness Center, Hallandale, Florida 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Zeltiq Aesthetics Inc, Medical Equipment, Key Facts, 2016 2
Zeltiq Aesthetics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Zeltiq Aesthetics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Zeltiq Aesthetics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Zeltiq Aesthetics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Zeltiq Aesthetics Inc, Deals By Market, 2011 to YTD 2017 8
Zeltiq Aesthetics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Galderma Enters into Agreement with ZELTIQ Aesthetics 10
Advance Medical Enters Into Co-Marketing Agreement With Zeltiq Aesthetics For CoolSculpting System 11
Zeltiq Aesthetics Files Registration Statement For Public Offering Of Securities For US$75 Million 12
ZELTIQ Aesthetics Completes IPO For US$101 Million 13
Allergan Acquires ZELTIQ Aesthetics for USD2.48 Billion 15
Zeltiq Aesthetics Inc, Key Competitors 17
Zeltiq Aesthetics Inc, Key Employees 18
Zeltiq Aesthetics Inc, Subsidiaries 19

★海外企業調査レポート[Zeltiq Aesthetics Inc (ZLTQ)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Placon Corporation:企業の戦略・SWOT・財務情報
    Placon Corporation - Strategy, SWOT and Corporate Finance Report Summary Placon Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Collagen Solutions Plc (COS):医療機器:M&Aディール及び事業提携情報
    Summary Collagen Solutions Plc (Collagen Solutions), formerly Healthcare Investment Opportunities Plc, is a medical device company that develops, manufactures and supplies medical grade collagen biomaterials and components. The company provides sourcing and supply of high grade collagen; provision o …
  • Knight-Swift Transportation Holdings Inc (KNX):企業の財務・戦略的SWOT分析
    Knight-Swift Transportation Holdings Inc (KNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Viamet Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Viamet Pharmaceuticals Inc (Viamet), a subsidiary of Viamet Pharmaceuticals Holdings LLC, discovers and develops novel medicinal drugs based on metalloenzyme chemistry and biology technology platform. Its product pipeline includes clinical-stage compounds such as VT-1161, an oral inhibitor u …
  • EnQuest PLC (ENQ):企業の財務・戦略的SWOT分析
    Summary EnQuest Plc (EnQuest) is an independent oil and gas exploration and production company. The company’s assets include producing oil fields, portfolio of discoveries, and new developments. Its oil and gas exploration assets are located in the UK North Sea and also have presence in oil basins o …
  • WorldPay US Inc:企業の戦略・SWOT・財務情報
    WorldPay US Inc - Strategy, SWOT and Corporate Finance Report Summary WorldPay US Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • BioView Ltd (BIOV)-医療機器分野:企業M&A・提携分析
    Summary BioView Ltd (BioView) is a medical device company that develops, manufactures and markets automated cell imaging and analysis solutions, which incorporate proprietary imaging, analysis and review technology. The technology provides automatic control of fully motorized fluorescent and bright- …
  • Ingles Markets Inc:企業の戦略・SWOT・財務情報
    Ingles Markets Inc - Strategy, SWOT and Corporate Finance Report Summary Ingles Markets Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • James Cropper PLC (CRPR):企業の財務・戦略的SWOT分析
    James Cropper PLC (CRPR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Teva Pharmaceutical Industries Ltd (TEVA):医療機器:M&Aディール及び事業提携情報
    Summary Teva Pharmaceutical Industries Ltd (Teva) is a pharmaceutical company that carries out the research, development, manufacture and commercialization of generic and specialty medicines. It provides specialty medicines to treat disorders of the central nervous system (CNS), respiratory, cancer, …
  • Medline Industries Inc:医療機器:M&Aディール及び事業提携情報
    Summary Medline Industries Inc (Medline) is a manufacturer and distributor of healthcare supplies in the US. The company offers products under various categories, including Exam Gloves, Textiles, Durable Medical Equipment, Skin Care, OR Kits, Protective Apparel, Gauze, Packs and Gowns, Bathing Syste …
  • DermTech Inc:医療機器:M&Aディール及び事業提携情報
    Summary DermTech Inc (DermTech) is a dermatology company that develops non-invasive gene expression tests to facilitate the early detection of skin cancers, assess inflammatory diseases, and customize drug treatments. The company’s products include adhesive skin sample collection kit, that allows co …
  • Ashtead Group Plc (AHT):企業の財務・戦略的SWOT分析
    Ashtead Group Plc (AHT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Capsugel Inc:企業の戦略的SWOT分析
    Capsugel Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Akashi Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Akashi Therapeutics Inc (Akashi Therapeutics), formerly DART Therapeutics Inc is a clinical stage biopharmaceutical company develops treatment for duchenne muscular dystrophy (DMD) and other rare pediatric diseases. The company provides pipeline portfolio such as HT-100, a small molecule dru …
  • Acxiom Corporation:企業の戦略・SWOT・財務情報
    Acxiom Corporation - Strategy, SWOT and Corporate Finance Report Summary Acxiom Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • TE Connectivity Ltd (TEL):企業の財務・戦略的SWOT分析
    TE Connectivity Ltd (TEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Bristol-Myers Squibb Co (BMY)-製薬・医療分野:企業M&A・提携分析
    Summary Bristol-Myers Squibb Company (BMS) is specialty biopharmaceutical company that carries out the discovery, development, licensing, manufacturing, marketing, distribution and sale of medicines to patients with serious diseases. Its primary focus is in cancer, cardiovascular, immunoscience and …
  • Applied Materials Inc (AMAT):企業の財務・戦略的SWOT分析
    Applied Materials Inc (AMAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Small Industries Development Bank of India:企業のM&A・事業提携・投資動向
    Small Industries Development Bank of India - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Small Industries Development Bank of India Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detai …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆